Effect of the JAK1 Inhibitor, Upadacitinib, on Skin Barrier Repair of Eczema Elicited During Anti-Interleukin-17 Treatment for Psoriasis
Dermatitis
.
2023 Dec 29.
doi: 10.1089/derm.2023.0298.
Online ahead of print.
Authors
Shuhong Ye
1
,
Biao Yu
2
,
Jiawen Wu
1
,
Zining Xu
1
,
Bingyang Xu
1
,
Hong Sun
3
,
Bin Zhao
4
Affiliations
1
Department of Dermatology, Xi'an Jiaotong University Second Affiliated Hospital, Xi'an, China.
2
Department of Dermatology, Taihe Hospital, Hubei University of Medicine, Shiyan, China.
3
Department of Neurology, Xi'an Jiaotong University Second Affiliated Hospital, Xi'an, China.
4
Department of Dermatology, Xi'an International Medical Center Hospital, Xi'an, China.
PMID:
38156810
DOI:
10.1089/derm.2023.0298
No abstract available